Suchergebnisse - "Daperno, Marco"

PubPharm (15)

1

Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD : Results from a Delphi consensus

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Ardizzone, S. | Armuzzi, A. | Caprioli, F. | +8

2

A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologics

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Degli Esposti, L. | Daperno, M. | Dovizio, M. | +8

3

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis : IG-IBD clinical guidelines based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Macaluso, F. | Orlando, A. | Papi, C. | +55

4

Who are the patients with Crohn's disease unsuitable to receive an anti-TNFα therapy? Results from a survey of Italian physicians and literature review

enthalten in: European journal of gastroenterology & hepatology | 2021

von Caprioli, F. | Daperno, M. | Bravatà, I. | +4

5

Switching from infliximab originator to a first biosimilar is safe and effective. Results of a case-control study with drug levels and antibodies evaluation

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2019

von Guiotto, C. | Italia, A. | Lavagna, A. | +6

6

Use of biosimilars in inflammatory bowel disease : a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2019

von Fiorino, G. | Caprioli, F. | Daperno, M. | +92

7

Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel disease

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2016

von Guiotto, C. | Daperno, M. | Frigerio, F. | +8

8

Use of biosimilars in inflammatory bowel disease : Statements of the Italian Group for Inflammatory Bowel Disease

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2014

von Annese, V. | Vecchi, M. | Italian Group for the Study of IBD (IG-IBD) | +22

9

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis : early and late outcome and predictors of colectomy

enthalten in: Journal of Crohn's & colitis | 2014

von Monterubbianesi, R. | Aratari, A. | Armuzzi, A. | +16

CommentIn: J Crohns Colitis. 2014 Oct;8(10):1327-8. - PMID 24631323

10

Ulcerative colitis : Rescue immune suppression for severe colitis--worth the risk?

enthalten in: Nature reviews. Gastroenterology & hepatology | 2011

von Actis, G. | Daperno, M.

CommentOn: Nat Rev Gastroenterol Hepatol. 2011 Jun;8(6):299. - PMID 21522114